Curtiland Deville, MD
Disclosures: Nothing to disclose

Brief Bio

 

Dr. Curtiland Deville is an Associate Professor in the Department of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins University School of Medicine. He serves as Clinical Director and Chair of Sibley Radiation Oncology and the Associate Director of the Johns Hopkins National Proton Therapy Center.

 

He is a graduate of Brown University’s combined undergraduate and graduate Program in Liberal Medical Education (PLME) and a past Doris Duke Clinical Research Fellow at the Yale Cancer Center. He completed his transitional year internship in internal medicine at Harbor Hospital Center in Baltimore, Maryland, and residency in radiation oncology at the Hospital of the University of Pennsylvania, where he joined the junior faculty as an Assistant Professor and served as clinical Chief of the Genitourinary (GU) and Sarcoma Services in the Department of Radiation Oncology and Roberts Proton Therapy Center.

 

Dr. Deville’s clinical expertise is in treating patients with soft tissue sarcoma and GU malignancies. His research interests include improving tumor targeting and assessing the toxicity profiles using modern radiation techniques such as proton and photon therapy. He has evaluated the implementation of proton therapy for novel indications such as post-prostatectomy therapy, pencil beam scanning, and plan robustness evaluations. He has co-authored over 100 peer-reviewed publications, including the first paper ever on the clinical use of post-prostatectomy proton therapy and textbook chapters on the use of proton therapy for soft tissue sarcoma and prostate cancer. He is on the research investigative team for the largest national trial comparing proton and photon therapy (COMPPARE), and serves as a Senior GU editor for the journal, Advances in Radiation Oncology.

 

Dr. Deville also has a research interest in physician workforce diversity in specialties that are disproportionately underrepresented by women and minorities. He serves as the Immediate Past Chair of the American Society for Radiation Oncology’s (ASTRO) Committee on Health Equity, Diversity and Inclusion, and as the Chair of the American Society for Clinical Oncology’s (ASCO) Diversity in Oncology Subcommittee.

 

Links:

Johns Hopkins Medicine profile

Pubmed

Orcid

Google Scholar

 

Proton-related manuscripts:

  1. Butala AA, Ingram WS, O'Reilly SE, Hartl B, Kassaee A, Deville C, Vapiwala N. Robust treatment planning in whole pelvis pencil beam scanning proton therapy for prostate cancer. Med Dosim. 2020 May 26;. doi: 10.1016/j.meddos.2020.04.001. PubMed PMID: 32471604.
  2. Deville C Jr, Hwang WT, Barsky AR, Both S, Christodouleas JP, Bekelman JE, Tochner Z, Vapiwala N. Initial clinical outcomes for prostate cancer patients undergoing adjuvant or salvage proton therapy after radical prostatectomy. Acta Oncol. 2020 May 18;:1-5. doi: 10.1080/0284186X.2020.1766698. PubMed PMID: 32421456.
  3. Santos PMG, Barsky AR, Hwang WT, Deville C, Wang X, Both S, Bekelman JE, Christodouleas JP, Vapiwala N. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting. Cancer. 2019 Dec 1;125(23):4278-4293. doi: 10.1002/cncr.32457. Epub 2019 Sep 10. PubMed PMID: 31503338; PubMed Central PMCID: PMC6856399.
  4. Deville C Jr, Jain A, Hwang WT, Woodhouse KD, Both S, Wang S, Gabriel PE, Christodouleas JP, Bekelman J, Tochner Z, Vapiwala N. Initial report of the genitourinary and gastrointestinal toxicity of post-prostatectomy proton therapy for prostate cancer patients undergoing adjuvant or salvage radiotherapy. Acta Oncol. 2018 Nov;57(11):1506-1514.
  5. Woodhouse KD, Hwang WT, Vapiwala N, Jain A, Wang X, Both S, Shah M, Frazier M, Gabriel P, Christodouleas J, Tochner Z, Deville C. Sociodemographic Disparities in the Utilization of Proton Therapy for Prostate Cancer at an Urban, Academic Center. Advances Rad Onc. 2016 April–June; 2(2):132–9.
  6. Shah A, Efstathiou JA, Paly JJ, Halpern SD, Bruner DW, Christodouleas JP, Coen JJ, Deville C Jr, Vapiwala N, Shipley WU, Zietman AL, Hahn SM, Bekelman JE. Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e13-9. PubMed PMID: 22381899.
  7. Christodouleas JP, Tang S, Susil RC, McNutt TR, Song DY, Bekelman J, Deville C, Vapiwala N, Deweese TL, Lu HM, Both S. The effect of anterior proton beams in the setting of a prostate-rectum spacer. Med Dosim. 2013 Autumn;38(3):315-9. PubMed PMID: 23578497; PubMed Central PMCID: PMC3968918.
  8. Tang S, Deville C, McDonough J, Tochner Z, Wang KK, Vapiwala N, Both S. Effect of intrafraction prostate motion on proton pencil beam scanning delivery: a quantitative assessment. Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):375-82. PubMed PMID: 23958148.
  9. Both S, Shen J, Kirk M, Lin L, Tang S, Alonso-Basanta M, Lustig R, Lin H, Deville C, Hill-Kayser C, Tochner Z, McDonough J. Development and clinical implementation of a universal bolus to maintain spot size during delivery of base of skull pencil beam scanning proton therapy. Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):79-84. PubMed PMID: 25195989.
  10. Kirk ML, Tang S, Zhai H, Vapiwala N, Deville C, James P, Bekelman JE, Christodouleas JP, Tochner Z, Both S. Comparison of prostate proton treatment planning technique, interfraction robustness, and analysis of single-field treatment feasibility. Pract Radiat Oncol. 2014 Oct 11;PubMed PMID: 25413411.
  11. Fang P, Mick R, Deville C, Both S, Bekelman JE, Christodouleas JP, Guzzo TJ, Tochner Z, Hahn SM, Vapiwala N. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer. Cancer. 2015 Apr 1;121(7):1118-27. doi: 10.1002/cncr.29148. PubMed PMID: 25423899.
  12. Tang S, Deville C, Tochner Z, Wang KK, McDonough J, Vapiwala N, Both S. Impact of intrafraction and residual interfraction effect on prostate proton pencil beam scanning. Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1186-94. PubMed PMID: 25442043.
  13. Baumann BC, Noa K, Wileyto EP, Bekelman JE, Deville C, Vapiwala N, Kirk M, Both S, Dolney D, Kassaee A, Christodouleas JP. Adjuvant radiation therapy for bladder cancer: a dosimetric comparison of techniques. Med Dosim. 2015 Winter;40(4):372-7. PubMed PMID: 26323390.
  14. Guttmann DM, Frick MA, Carmona R, Deville Jr C, Levin WP, Berman AT, Chinniah C, Hahn SM, Plastaras JP, Simone II CB. A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma. Radiother Oncol. 2017 Jul 8;PubMed PMID: 28697854.
  15. Ben-Josef AM, Chen J, Wileyto P, Doucette A, Bekelman J, Christodouleas J, Deville C, Vapiwala N. Effect of Eischens Yoga During Radiation Therapy on Prostate Cancer Patient Symptoms and Quality of Life: A Randomized Phase II Trial. Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1036-1044. PubMed PMID: 28721886.
  16. Deville C, Ben-Josef E, Vapiwala N. Radiation therapy modalities for prostate cancer. JAMA. 2012 Aug 1;308(5):451; author reply 451-2. PubMed PMID: 22851101.

 

Proton-related book chapters:

  1. Deville C, Ladra M, Zhai H, Siddiqui M, Both S, Lin H. Chapter Sarcoma. In: Lee N (ed.) Target Volume Delineation and Treatment Planning for Particle Therapy, 1st ed. SpringerLink, 2018.
  2. Deville C. Chapter 46. Proton Beam Therapy. In: Mydlo JH, Godec CJ (eds.) Prostate Cancer: Science and Clinical Practice, 2nd ed. Elsevier Press, 2015.
  3. Deville C, Shukla G, Rengan R, Thomas CR. Chapter 17. Radiotherapy. In: Gansler T (ed.) American Cancer Society Textbook of Cancer, 2nd ed. Wiley-Blackwell Publishing: Oxford, 2017.